Pyrrolidine dithiocarbamate inhibits UVB-induced skin inflammation and oxidative stress in hairless mice and exhibits antioxidant activity in vitro.
Ana L M Ivan, Marcela Z Campanini, Renata M Martinez, Vitor S Ferreira, Vinicius S Steffen, Fabiana T M C Vicentini, Fernanda M P Vilela, Frederico S Martins, Ana C Zarpelon, Thiago M Cunha, Maria J V Fonseca, Marcela M Baracat, Sandra R Georgetti, Waldiceu A Verri, Rúbia Casagrande
文献索引:J. Photochem. Photobiol. B, Biol. 138 , 124-33, (2014)
全文:HTML全文
摘要
Ultraviolet B (UVB) irradiation may cause oxidative stress- and inflammation-dependent skin cancer and premature aging. Pyrrolidine dithiocarbamate (PDTC) is an antioxidant and inhibits nuclear factor-κB (NF-κB) activation. In the present study, the mechanisms of PDTC were investigated in cell free oxidant/antioxidant assays, in vivo UVB irradiation in hairless mice and UVB-induced NFκB activation in keratinocytes. PDTC presented the ability to scavenge 2,2'-azinobis-(3-ethyl benzothiazoline-6-sulfonic acid) radical (ABTS), 2,2-diphenyl-1-picryl-hydrazyl radical (DPPH) and hydroxyl radical (OH); and also efficiently inhibited iron-dependent and -independent lipid peroxidation as well as chelated iron. In vivo, PDTC treatment significantly decreased UVB-induced skin edema, myeloperoxidase (MPO) activity, production of the proinflammatory cytokine interleukin-1β (IL-1β), matrix metalloproteinase-9 (MMP-9), increase of reduced glutathione (GSH) levels and antioxidant capacity of the skin tested by the ferric reducing antioxidant power (FRAP) and ABTS assays. PDTC also reduced UVB-induced IκB degradation in keratinocytes. These results demonstrate that PDTC presents antioxidant and anti-inflammatory effects in vitro, which line up well with the PDTC inhibition of UVB irradiation-induced skin inflammation and oxidative stress in mice. These data suggest that treatment with PDTC may be a promising approach to reduce UVB irradiation-induced skin damages and merits further pre-clinical and clinical studies. Copyright © 2014 Elsevier B.V. All rights reserved.
相关化合物
相关文献:
2015-03-01
[Int. Immunopharmacol. 25(1) , 19-29, (2015)]
2015-01-15
[Arch. Biochem. Biophys. 566 , 15-25, (2015)]
2015-03-01
[PLoS Genet. 11(3) , e1004977, (2015)]
2015-02-15
[J. Immunol. 194(4) , 1776-87, (2015)]
2015-03-01
[Bioorg. Med. Chem. 23(5) , 1123-34, (2015)]